Ephrin-B2 is a candidate ligand for the Eph receptor, EphB6

FEBS Letters

Volumn 466, Issue 1, 2000, Pages 169-174

  Munthe, Else ^a   Rian, Edith ^a   Holien, Toril ^a   Rasmussen, Anne Marie ^a   Levy, Finn Olav ^b   Aasheim, Hans Christian ^a  

^a INSTITUTE OF CANCER RESEARCH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Ligand; Reh cell line; Scatchard analysis; Tyrosine kinase

Indexed keywords

CELL RECEPTOR; EPHRIN; EPHRIN B2; EPHRIN B6 RECEPTOR; EPHRIN RECEPTOR; HYBRID PROTEIN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN COS1; HEMATOPOIETIC TISSUE; HUMAN; HUMAN CELL; LEUKEMIA CELL; LIGAND BINDING; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; BASE SEQUENCE; CELL LINE; COS CELLS; DNA PRIMERS; EPHRIN-B2; HUMANS; LIGANDS; MEMBRANE PROTEINS; MICE; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE; PHOSPHOLIPASE C; RECEPTOR PROTEIN-TYROSINE KINASES; RECOMBINANT FUSION PROTEINS; THYMUS GLAND; TISSUE DISTRIBUTION; TRANSFECTION;

EID: 0033956829     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(99)01793-7     Document Type: Article

References (48)

1. Schlesinger J., Ullrich A. Neuron. 9:1992;383-391.
2. Yarden Y., Ullrich A. Annu. Rev. Biochem. 57:1988;443-478.
3. Flanagan J.G., Vanderhaeghen P. Annu. Rev. Neurosci. 21:1998;309-345.
4. Holder N., Klein R. Development. 126:1999;2033-2044.
5. O'Leary D.D. Curr. Opin. Neurobiol. 9:1999;65-73.
6. Zhou R. Pharmacol. Ther. 77:1998;151-181.
7. Pasquale E.B. Curr. Opin. Cell. Biol. 9:1997;608-615.
8. Gale N.W., Holland S.J., Valenzuela D.M., Flenniken A., Pan L., Ryan T.E., Henkemeyer M., Strebhardt K., Hirai H., Wilkinson D.G., Pawson T., Davis S., Yancopoulos G.D. Neuron. 17:1996;9-19.
9. Holland S.J., Gale N.W., Mbamalu G., Yancopoulos G.D., Henkemeyer M., Pawson T. Nature. 383:1996;722-725.
10. Bruckner K., Pasquale E.B., Klein R. Science. 275:1997;1640-1643.
11. George S.E., Simokat K., Hardin J., Chisholm A.D. Cell. 92:1998;633-643.
12. Cheng H.J., Nakamoto M., Bergemann A.D., Flanagan J.G. Cell. 82:1995;371-381.
13. Gao P.P., Zhang J.H., Yokoyama M., Racey B., Dreyfus C.F., Black I.B., Zhou R. Proc. Natl. Acad. Sci. USA. 93:1996;11161-11166.
14. Winslow J.W., Moran P., Valverde J., Shih A., Yuan J.Q., Wong S.C., Tsai S.P., Goddard A., Henzel W.J., Hefti F. Neuron. 14:1995;973-981.
15. Henkemeyer M., Orioli D., Henderson J.T., Saxton T.M., Roder J., Pawson T., Klein R. Cell. 86:1996;35-46.
16. Nakamoto M., Cheng H.J., Friedman G.C., McLaughlin T., Hansen M.J., Yoon C.H., O'Leary D.D., Flanagan J.G. Cell. 86:1996;755-766.
17. Helbling P.M., Tran C.T., Brandli A.W. Mech. Dev. 78:1998;63-79.
18. Krull C.E., Lansford R., Gale N.W., Collazo A., Marcelle C., Yancopoulos G.D., Fraser S.E., Bronner-Fraser M. Curr. Biol. 7:1997;571-580.
19. Smith A., Robinson V., Patel K., Wilkinson D.G. Curr. Biol. 7:1997;561-570.
20. Wang H.U., Anderson D.J. Neuron. 18:1997;383-396.
21. Xu Q., Alldus G., Holder N., Wilkinson D.G. Development. 121:1995;4005-4016.
22. Winning R.S., Scales J.B., Sargent T.D. Dev. Biol. 179:1996;309-319.
23. Pandey A., Shao H., Marks R.M., Polverini P.J., Dixit V.M. Science. 268:1995;567-569.
24. Wang H.U., Chen Z.F., Anderson D.J. Cell. 93:1998;741-753.
25. Berclaz G., Andres A.C., Albrecht D., Dreher E., Ziemiecki A., Gusterson B.A., Crompton M.R. Biochem. Biophys. Res. Commun. 226:1996;869-875.
26. Maru Y., Hirai H., Takaku F. Oncogene. 5:1990;445-447.
27. Nikolova Z., Djonov V., Zuercher G., Andres A.C., Ziemiecki A. J. Cell Sci. 111:1998;2741-2751.
28. Vogt T., Stolz W., Welsh J., Jung B., Kerbel R.S., Kobayashi H., Landthaler M., McClelland M. Clin. Cancer Res. 4:1998;791-797.
29. Labrador J.P., Brambilla R., Klein R. EMBO J. 16:1997;3889-3897.
30. Matsuoka H., Iwata N., Ito M., Shimoyama M., Nagata A., Chihara K., Takai S., Matsui T. Biochem. Biophys. Res. Commun. 235:1997;487-492.
31. Tang X.X., Biegel J.A., Nycum L.M., Yoshioka A., Brodeur G.M., Pleasure D.E., Ikegaki N. Genomics. 29:1995;426-437.
32. Stamenkovic I., Seed B. J. Exp. Med. 168:1988;1205-1210.
33. Beckman M.P., Ceretti P.D., Baum P., Vanden Bos T., James L., Farrah T., Kozlosky C., Hollingsworth T., Shilling H., Maraskovsky E., Fletcher F.A., Lhotak V., Pawson T., Lyman S.D. EMBO J. 13:1994;3757-3762.
34. Cerretti D.P., Vanden Bos T., Nelson N., Kozlosky C.J., Reddy P., Maraskovsky E., Park L.S., Lyman S.D., Copeland N.G., Gilbert D.J. Mol. Immunol. 32:1995;1197-1205.
35. Aruffo A., Seed B. Proc. Natl. Acad. Sci. USA. 84:1987;8573-8577.
36. Scatchard G. Ann. N.Y. Acad. Sci. 51:1949;660-672.
37. Aasheim H.-C., Logtenberg T., Larsen F. Methods Mol. Biol. 69:1996;115-128.
38. Cheng H.J., Flanagan J.G. Cell. 79:1994;157-168.
39. Kay R., Rosten P.M., Humphries R.K. J. Immunol. 147:1991;1412-1416.
40. Eph Nomenclature Committee (1997) Cell 90, 403-404.
41. Tang X.X., Pleasure D.E., Ikegaki N. Genomics. 41:1997;17-24.
42. Bennett B.D., Zeigler F.C., Gu Q., Fendly B., Goddard A.D., Gillett N., Matthews W. Proc. Natl. Acad. Sci. USA. 92:1995;1866-1870.
43. Brambilla R., Bruckner K., Orioli D., Bergemann A.D., Flanagan J.G., Klein R. Mol. Cell. Neurosci. 8:1996;199-209.
44. Sakano S., Serizawa R., Inada T., Iwama A., Itoh A., Kato C., Shimizu Y., Shinkai F., Shimizu R., Kondo S., Ohno M., Suda T. Oncogene. 13:1996;813-822.
45. Goodwin R.G., Alderson M.R., Smith C.A., Armitage R.J., VandenBos T., Jerzy R., Tough T.W., Schoenborn M.A., Davis-Smith T., Hennen K. Cell. 73:1993;447-456.
46. Davis S., Gale N.W., Aldrich T.H., Maisonpierre P.C., Lhotak V., Pawson T., Goldfarb M., Yancopoulos G.D. Science. 266:1994;816-819.
47. Ciossek T., Ullrich A. Oncogene. 14:1997;35-43.
48. Gurniak C.B., Berg L.J. Oncogene. 13:1996;777-786.